Suppression of GLUT1; A new strategy to prevent diabetic complications

Journal of Cellular Physiology

Volumn 228, Issue 2, 2013, Pages 251-257

  Lu, Lili ^a   Seidel, Christopher P ^a   Iwase, Takeshi ^a   Stevens, Rebecca K ^a   Gong, Yuan Yuan ^a   Wang, Xinyi ^a   Hackett, Sean F ^a   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,9 DIDEOXYFORSKOLIN; ADENYLATE CYCLASE; ANTIDIABETIC AGENT; BETA 2 CRYSTALLIN; BETA CRYSTALLIN; BIOLOGICAL MARKER; CYCLIC AMP; FORSKOLIN; GENISTEIN; GLUCOSE; GLUCOSE TRANSPORTER 1; GLYCOSYLATED HEMOGLOBIN; MESSENGER RNA; MYRICETIN; SMALL INTERFERING RNA; STREPTOZOCIN; SUPEROXIDE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG BINDING; DRUG EFFICACY; ERYTHROCYTE; FETUS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GROWTH INHIBITION; HEMOGLOBIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA; STREPTOZOCIN DIABETES;

ANIMALS; BETA-CRYSTALLIN B CHAIN; BLOOD GLUCOSE; BRAIN; BRAIN CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ERYTHROCYTES; FORSKOLIN; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENISTEIN; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; MALE; MICE; PROTEIN KINASE INHIBITORS; RETINA; SUPEROXIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MUS;

EID: 84868020394     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24133     Document Type: Article

References (36)

1. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Sihibuya M, Fukami Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
2. Andley UP. 2007. Crystallins in the eye: Function and pathology. Prog Ret Eye Res 26:78-98.
3. Bryant NJ, Govers R, James DE. 2002. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3:267-277.
4. Chen B, Caballero S, Seo S, Grant MB, Lewin AS. 2009. Delivery of antioxidant enzyme genes to protect against ischemia/reperfusion induced injury to retinal vasculature. Invest Ophthalmol Vis Sci 50:5587-5595.
5. Cloherty EK, Diamond DL, Heard KS, Carruthers A. 1996. Regulation of GLUT1-mediated sugar transport by an antiport/uniport switch mechanism. Biochemistry 35:13231-13239.
6. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M. 2000. Hyperglycemia-induced mitochondrial superoxide over-production activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci US A 97:12222-12226.
7. Fort PE, Freeman WM, Losiewicz MK, Singh RJ. 2009. The retinal proteome in experimental diabetic retinopathy. Upregulation of cystallins and reversal by systemic and periocular insulin. Mol Cell Proteomics 8:767-779.
8. Georgiou CD, Papapostolou I, Grintzalis K. 2008. Superoxide radical detection in cells, tissues, organisms (animals, plants, insects, microorganisms) and soils. Nat Protoc 3:1679-1692.
9. Giacco F, Brownlee M. 2010. Oxidative stress and diabetic complications. Circ Res 107:1058-1070.
10. Goto H, Nishikawa T, Sonoda K, Kondo T, Kukidome D, Fujisawa K, Yamashiro T, Motoshima H, Matsumura T, Tsuruzoe K, Araki E. 2008. Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. Biochem Biophys Res Commun 366:814-820.
11. The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986.
12. The Diabetes Control and Complications Trial Research Group. 1995. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 102:647-661.
13. Hayashida N, Chihara S, Tayama E, Takaseya T, Enomoto N, Kawara T, Aoyagi S. 2001. Antiinflammatory effects of colforsin daropate hydrochloride, a novel water-soluble forskolin derivative. Ann Thorac Surg 71:1931-1938.
14. Joost HG, Habberfield AD, Simpson IA, Laurenza A, Seamon KB. 1988. Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: Structural determinants for distinct sites of action. Mol Pharmacol 33:449-453.
15. Kashiwagi A, Huecksteadt TP, Foley JE. 1983. The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes. J Biol Chem 258:13685-13692.
16. Kim HD, Sergeant S, Shukla SD. 1986. Glucose transport in human platelets and its inhibition by forskolin. J Pharmacol Exp Ther 236:585-589.
17. Kowluru RA, Chan P-S. 2007. Oxidative stress and diabetic retinopathy. Exp Diabetes Res DOI: 10.1155/2007/43603:1-12.
18. Kumagai AK, Glasgow BJ, Pardridge WM. 1994. GLUT1 glucose transporter expression in the human diabetic and non-diabetic eye. Invest Ophthalmol Vis Sci 35:2887-2894.
19. Kumar PA, Haseeb A, Suryanarayana P, Ehtesham NZ, Reddy GB. 2005. Elevated expression of alphaA- and alphaB-crystallins in streptozotocin-induced diabetic rat. Arch Biochem Biophys 444:77-83.
20. Losiewicz MK, Fort PE. 2011. Diabetes impairs the neuroprotective properties of retinal alpha-crystallins. Invest Ophthalmol Vis Sci 52:5034-5042.
21. Mantych GS, Hageman GS, Devaskar SU. 1993. Characterization of glucose transporter isoforms in the adult and developing human eye. Endocrinology 133:600-607.
22. Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y. 1998. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci 39:2190-2194.
23. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790.
24. Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, Frank RN, Stevens MJ. 2001. Antioxidants attenuate early up regulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 44:1102-1110.
25. Pardridge WM, Boado RJ, Farrell CR. 1990. Brain type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem 265:18035-18040.
26. Pietch A, Dessy C, Havaux X, Feron O, Balligand JL. 2003. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 57:456-467.
27. Schroder A, Palinski W, Schmid-Schonbein G. 1991. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 139:81-100.
28. Seamon KB, Daly JW. 1981. Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci USA 78:3363-3367.
29. Sergeant S, Kim HD. 1985. Inhibition of 3-O-methylglucose transport in human erythrocytes by forskolin. J Biol Chem 260:14677-14682.
30. 3H]Forskolin, direct photoaffinity labeling of the erythrocyte D-glucose transporter. J Biol Chem 262:5978-5984.
31. Shen J, Yang XR, Xiao WH, Hackett SF, Sato Y, Campochiaro PA. 2006. Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J 20:723-725.
32. Uldry M, Thorens B. 2004. The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch 447:480-489.
33. Vera JC, Reyes AM, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Sebe JC, Nunez-Alarcon J, Golde DW. 2001. Direct inhibition of the hexose tranporter GLUT1 by tyrosine kinase inhibitors. Biochemistry 40:777-790.
34. Wajima Z, Shiga T, Yoshikawa T, Ogura A, Imanaga K, Inoue T, Ogawa R. 2003. Effect of prophylactic bronchodilator treatment with intravenous colforsin daropate, a water-soluble forkolin derivative, on airway resistance after tracheal intubation. Anesthesiology 99:18-26.
35. Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi T, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T. 2006. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. J Biol Chem 281:20213-20220.
36. Zhao FQ, Keating AF. 2007. Functional properties and genomics of glucose transporters. Curr Genomics 8:113-128.